Click here for slides on this topic


Glucose tolerance test

See oral glucose tolerance test.
The following content matched the glossary term: Glucose tolerance test

Endocrine Society Guideline on Diabetes and Pregnancy - Glycemic Targets & Glucose Management

Top

Diabetes Management Guidelines Endocrine Society Guideline on Diabetes and Pregnancy   Source Blumer I, Hadar E, Hadden DR, et al. Diabetes and pregnancy an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013 98(11) 4227 4249. Available here.Refer to

ADA 2016 Diabetes Screening and Diagnosis

Top

Criteria for type 2 diabetes diagnosis from the 2016ADA guidelines

American Diabetes Association 72nd Scientific Sessions Daily Coverage June 9, 2012

Top

Daily coverage of American Diabetes Association 72nd Scientific Sessions  June 9, 2012

Results from the EASIE, EUREXA, TODAY, and Diabetes Prevention Program (DPP) trials; new data on SGLT2 inhibitors for diabetes treatment, incretins for diabetes treatment, ATP-IV guideline update, and more.

 

Clinical Insights in Diabetes Newsletter Archive

Top

Clinical Insights® in Diabetes Newsletter Archive

Utility of hemoglobin a1c for diagnosing prediabetes and diabetes in obese children and adolescents

Top

Nowicka P, Santoro N, Liu H, Lartaud D, Shaw MM, Goldberg R, Guandalini C, Savoye M, Rose P, Caprio S. Utility of hemoglobin a1c for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care. 2011;34(6):1306-11. Hemoglobin A(1c) (A1C) has emerged as a recommended diagnostic tool for identifying diabetes and subjects at risk for the disease. This recommendation is based on data in adults showing the relationship between A1C with future development of diabetes and microvascular complications. However, studies in the pediatric population are lacking.

Hemoglobin A1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction: a 6-year community-based prospective study

Top

Choi SH, Kim TH, Lim S, Park KS, Jang HC, Cho NH. Hemoglobin A1c as a diagnostic tool for diabetes screening and new onset diabetes prediction a 6 year community based prospective study. Diabetes Care. 2011 Feb 18. Epub ahead of print. Various cutoff levels of hemoglobin A(1c) (A1C) have been suggested to screen for diabetes, although more consensus about the best level, especially for different ethnicities, is required.

The relationship between {beta}-cell function and glycated hemoglobin: results from the Veterans Administration Genetic Epidemiology study

Top

The relationship between beta cell function and glycated hemoglobin results from the Veterans Administration Genetic Epidemiology studyKanat M, Winnier D, Norton L, Arar N, Jenkinson C, Defronzo RA, Abdul Ghani MA.Diabetes Care. 2011 Feb 25. Epub ahead of print. The study objective was to assess the relationship between β-cell function and HbA(1c).

Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study

Top

Zinman B, Harris SB, Neuman J, Gerstein HC, Retnakaran RR, Raboud J, Qi Y, Hanley AJ. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study. Lancet. 2010;376(9735):103-111. The evolving epidemic of type 2 diabetes has challenged health-care providers to assess the safety and efficacy of various diabetes prevention strategies. The CANOE (CAnadian Normoglycemia Outcomes Evaluation) trial investigated whether low-dose combination therapy would affect development of type 2 diabetes.

Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies

Top

Ruchat SM, Elks CE, Loos RJ, et al. Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies. Acta Diabetol. 2009;46(3):217-226. Several single nucleotide polymorphisms (SNPs) for type 2 diabetes mellitus (T2DM) risk have been identified by genome wide association studies (GWAS).

Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study

Top

Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Diabetes Care. 2009;373(9682):2215-2221. Pioglitazone (PIO), a thiazolidinedione (TZD), is reported to be highly effective in the treatment of type 2 diabetes mellitus, but is associated with edema, heart failure, and weight gain. This study documented long-term tolerability outcomes of patients taking pioglitazone and assessed how troublesome these adverse events were for the patients.

1 2 3 4 5 6 7 8 9 Next 

Slide Library Results

Search Results for: Glucose tolerance test Slides Found: 36
Risk Factors for Conversion to Diabetes in Mexican Americans
Type 2 Diabetes Prevention Studies
Effect of Bariatric Surgery on Acute Insulin Response
GLP-1 and First-Phase Insulin Secretion
Single Doses of Sitagliptin Increase Incretin Levels Over 24 Hours
Normal Relationship Between Insulin Sensitivity and Response: The Disposition Index
Early Nutrient-Induced Insulin Secretion
Fasting Plasma Glucose and the Acute Insulin Response
Tools to Assess beta-Cell Health and Function
DECODE: IFG and IGT Are Associated With Increased Mortality Rate
Prevalence of IFG, IGT, and Prediabetes by Cardiometabolic Risk Factors
Prevalence of IFG, IGT, and Prediabetes According to a Combination of Central Obesity and Hyperinsulinemia
Whitehall II: Design
Whitehall II: Fasting Glucose From Baseline to 13 Years
Whitehall II: 2-Hour Postload Glucose From Baseline to 13 Years
Whitehall II: HOMA Insulin Sensitivity Trajectory Before Diagnosis of Diabetes or End of Follow-Up
Whitehall II: HOMA b-Cell Function Trajectory Before Diagnosis of Diabetes or End of Follow-Up
Whitehall II: Conclusion
Whitehall II: 2-Hour Postload Glucose From Baseline to 13 Years
ESH/ESC Hypertension Guidelines: Individuals at Higher CV Risk
Liraglutide Improves ß-Cell Function and Insulin Secretion During Hyperglycemia in Patients With Type 2 Diabetes
Diabetes Pregnancy Guidelines GDM Testing Endocrine Society | NDEI
ADA Type 1 Diabetes Guidelines Diagnostic Criteria | NDEI
SCALE Obesity & Prediabetes Trial Liraglutide Hypoglycemia PPT | NDEI
Gut Microbiota & Glycemic Control ENDO2015 Diabetes PPT | NDEI
AACE 2015 Diabetes Guidelines Prediabetes Diagnosis IFG IGT PPT | NDEI
AACE 2015 Diabetes Guidelines Gestational Diabetes Diagnosis PPT | NDEI
Type 2 Diabetes Screening US Preventive Type 2 Diabetes Guidelines | NDEI
Blood Glucose Values Indicating Prediabetes or Type 2 Diabetes
Type 2 Diabetes Diagnostic Criteria US Preventive Guidelines | NDEI
Criteria for Type 2 Diabetes Diagnosis ADA Guidelines 2016 | NDEI PPT
Prediabetes Increases Type 2 Diabetes Risk ADA Guidelines | NDEI PPT
Gestational Diabetes Mellitus (GDM) Diagnosis ADA Guidelines | NDEI PPT
Diagnosing Gestational Diabetes Mellitus GDM ADA Guidelines | NDEI PPT
Postpartum Follow-Up for Women With Gestational Diabetes ADA Guidelines | NDEI
Cystic Fibrosis-Related Diabetes ADA Guidelines | NDEI PPT